Skip to content

Statement 6.5

“Hospital pharmacists should be actively involved in clinical trials of medicines.” 

What does it mean for patients? Patients can contribute to the development of new drugs by providing their informed consent to participate in a trial; testing of new medicines under the supervision of the principal investigator and a hospital pharmacist, who checks the quality and safety of the products. The hospital pharmacist is responsible for the preparation and distribution of these investigational medicines.

What does it mean for healthcare professionals? Hospital pharmacists can be relied on to establish safe procedures and protocols to comply with legislation concerning the use of the investigational medicines and their management.

What does it mean for Hospital Pharmacists? Hospital pharmacists should actively participate in the management of clinical trials and be responsible for the accountability, the preparation and the distribution of the investigational medicines.

 

The  Sindelfingen­Boeblingen Medical Center is SILCC Host providing training on this Statement. Please learn more about the SILCC programme here.

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.